MedPath

The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man

Not Applicable
Completed
Conditions
Insulin Resistance
Registration Number
NCT01957098
Lead Sponsor
University of Copenhagen
Brief Summary

The purpose of this study is to investigate the effect of L-arabinose and D-xylose in a sugar-rich drink on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose and D-xylose.

Detailed Description

Based on previous scientific results we hypotesize, that pentoses decreases the demand for insulin in metabolizing a given dose of sucrose.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
14
Inclusion Criteria
  • healthy males
  • BMI between 18.4-25 kg/m2
  • age between 18 and 30
Exclusion Criteria
  • donation of blood 3 months before or during the study
  • gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic infectious disease (HIV or hepatitis)
  • smoking
  • consumption of more than 21 alcoholic drinks/week
  • elite athletes
  • on medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Blood glucose, insulin, C-peptide and GLP-1-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of glucose, insulin, C-peptide and glucagon-like peptide-1 (GLP-1) over time, the area under the curve (AUC), the peak value and time to peak

Secondary Outcome Measures
NameTimeMethod
Appetite measurements and energy intake-15, 30, 60, 90, 120, 150 and 180 min

Appetite measurements: area under/over the curve (AUC/AOC), 3-h mean. Energy intake: the ad libitum energy intake at lunch was registered. VAS was used to asses the palatability (appearance, smell, taste, after-taste and overall palatability) of the ad libitum lunch.

Trial Locations

Locations (1)

Institute of Human Nutrition, The Royal Veterinary and Agricultural University

🇩🇰

Frederiksberg, Denmark

© Copyright 2025. All Rights Reserved by MedPath